Clinical Significance of Circulating Biomarkers of Immune Checkpoint Molecules with Atezolizumab Plus Bevacizumab Therapy in Unresectable Hepatocellular Carcinoma
Hepatology International(2024)
Key words
Atezolizumab plus bevacizumab,Hepatocellular carcinoma,Immune-checkpoint inhibitor,CXCL9,LAG-3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined